Basic Information
| LncRNA/CircRNA Name | FAM212B-AS1 |
| Synonyms | FAM212B-AS1 |
| Region | GRCh38_1:111739841-111747798 |
| Ensemble | ENSG00000227811 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | endometrial cancer |
| ICD-0-3 | NA |
| Methods | Microarray, qPCR etc. |
| Sample | endometrial carcinoma tissues |
| Expression Pattern | down-regulated |
| Function Description | Real-time PCR verified that 6 of the 7 lncRNAs are dramatically downregulated in EC, which is consistent with the microarray data. |
| Pubmed ID | 27748922 |
| Year | 2016 |
| Title | Distinct expression profile of lncRNA in endometrial carcinoma. |
External Links
| Links for FAM212B-AS1 | GenBank HGNC NONCODE |
| Links for endometrial cancer | OMIM COSMIC |